480 related articles for article (PubMed ID: 21646575)
1. In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users.
Erritzoe D; Frokjaer VG; Holst KK; Christoffersen M; Johansen SS; Svarer C; Madsen J; Rasmussen PM; Ramsøy T; Jernigan TL; Knudsen GM
Arch Gen Psychiatry; 2011 Jun; 68(6):562-76. PubMed ID: 21646575
[TBL] [Abstract][Full Text] [Related]
2. Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907.
Urban NB; Girgis RR; Talbot PS; Kegeles LS; Xu X; Frankle WG; Hart CL; Slifstein M; Abi-Dargham A; Laruelle M
Neuropsychopharmacology; 2012 May; 37(6):1465-73. PubMed ID: 22353758
[TBL] [Abstract][Full Text] [Related]
3. Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users.
Di Iorio CR; Watkins TJ; Dietrich MS; Cao A; Blackford JU; Rogers B; Ansari MS; Baldwin RM; Li R; Kessler RM; Salomon RM; Benningfield M; Cowan RL
Arch Gen Psychiatry; 2012 Apr; 69(4):399-409. PubMed ID: 22147810
[TBL] [Abstract][Full Text] [Related]
4. Brain serotonin transporter binding in former users of MDMA ('ecstasy').
Selvaraj S; Hoshi R; Bhagwagar Z; Murthy NV; Hinz R; Cowen P; Curran HV; Grasby P
Br J Psychiatry; 2009 Apr; 194(4):355-9. PubMed ID: 19336788
[TBL] [Abstract][Full Text] [Related]
5. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
6. Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.
Kish SJ; Lerch J; Furukawa Y; Tong J; McCluskey T; Wilkins D; Houle S; Meyer J; Mundo E; Wilson AA; Rusjan PM; Saint-Cyr JA; Guttman M; Collins DL; Shapiro C; Warsh JJ; Boileau I
Brain; 2010 Jun; 133(Pt 6):1779-97. PubMed ID: 20483717
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance.
McCann UD; Szabo Z; Vranesic M; Palermo M; Mathews WB; Ravert HT; Dannals RF; Ricaurte GA
Psychopharmacology (Berl); 2008 Oct; 200(3):439-50. PubMed ID: 18661256
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of molecular imaging of serotonin transporters in ecstasy/polydrug users.
Roberts CA; Jones A; Montgomery C
Neurosci Biobehav Rev; 2016 Apr; 63():158-67. PubMed ID: 26855234
[TBL] [Abstract][Full Text] [Related]
9. A nonlinear relationship between cerebral serotonin transporter and 5-HT(2A) receptor binding: an in vivo molecular imaging study in humans.
Erritzoe D; Holst K; Frokjaer VG; Licht CL; Kalbitzer J; Nielsen FA; Svarer C; Madsen J; Knudsen G
J Neurosci; 2010 Mar; 30(9):3391-7. PubMed ID: 20203198
[TBL] [Abstract][Full Text] [Related]
10. Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB.
McCann UD; Szabo Z; Seckin E; Rosenblatt P; Mathews WB; Ravert HT; Dannals RF; Ricaurte GA
Neuropsychopharmacology; 2005 Sep; 30(9):1741-50. PubMed ID: 15841106
[TBL] [Abstract][Full Text] [Related]
11. In abstinent MDMA users the cortisol awakening response is off-set but associated with prefrontal serotonin transporter binding as in non-users.
Frokjaer VG; Erritzoe D; Holst KK; Madsen KS; Fisher PM; Madsen J; Svarer C; Knudsen GM
Int J Neuropsychopharmacol; 2014 Aug; 17(8):1119-28. PubMed ID: 24524290
[TBL] [Abstract][Full Text] [Related]
12. Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers.
Erritzoe D; Smith J; Fisher PM; Carhart-Harris R; Frokjaer VG; Knudsen GM
J Psychopharmacol; 2019 Sep; 33(9):1068-1075. PubMed ID: 30816797
[TBL] [Abstract][Full Text] [Related]
13. Neuroimaging research in human MDMA users: a review.
Cowan RL
Psychopharmacology (Berl); 2007 Jan; 189(4):539-56. PubMed ID: 16847678
[TBL] [Abstract][Full Text] [Related]
14. The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies.
Vegting Y; Reneman L; Booij J
Psychopharmacology (Berl); 2016 Oct; 233(19-20):3473-501. PubMed ID: 27568200
[TBL] [Abstract][Full Text] [Related]
15. Serotonergic neurotransmission in emotional processing: New evidence from long-term recreational poly-drug ecstasy use.
Laursen HR; Henningsson S; Macoveanu J; Jernigan TL; Siebner HR; Holst KK; Skimminge A; Knudsen GM; Ramsoy TZ; Erritzoe D
J Psychopharmacol; 2016 Dec; 30(12):1296-1304. PubMed ID: 27599522
[TBL] [Abstract][Full Text] [Related]
16. Restoration of 3,4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of L-5-hydroxytryptophan.
Wang X; Baumann MH; Dersch CM; Rothman RB
Neuroscience; 2007 Aug; 148(1):212-20. PubMed ID: 17629409
[TBL] [Abstract][Full Text] [Related]
17. A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.
Buchert R; Thomasius R; Wilke F; Petersen K; Nebeling B; Obrocki J; Schulze O; Schmidt U; Clausen M
Am J Psychiatry; 2004 Jul; 161(7):1181-9. PubMed ID: 15229049
[TBL] [Abstract][Full Text] [Related]
18. Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects.
Reneman L; de Win MM; van den Brink W; Booij J; den Heeten GJ
J Psychopharmacol; 2006 Mar; 20(2):164-75. PubMed ID: 16510475
[TBL] [Abstract][Full Text] [Related]
19. Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditions.
Szabo Z; McCann UD; Wilson AA; Scheffel U; Owonikoko T; Mathews WB; Ravert HT; Hilton J; Dannals RF; Ricaurte GA
J Nucl Med; 2002 May; 43(5):678-92. PubMed ID: 11994534
[TBL] [Abstract][Full Text] [Related]
20. Serotonin transporter availability, neurocognitive function and their correlation in abstinent 3,4-methylenedioxymethamphetamine users.
van de Blaak FL; Dumont GJH
Hum Psychopharmacol; 2022 Jan; 37(1):e2811. PubMed ID: 34506649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
